2025 HCPCS Code J7633
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
TAGS: final inhalation through milligram administered concentrated| Short Description | Budesonide non-comp con |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2003 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J1570 - Ganciclovir sodium injection
- J1571 - Hepagam b im injection
- J1572 - Flebogamma injection
- J1573 - Hepagam b intravenous, inj
- J1574 - Inj, ganciclovir (exela)
- J1575 - Hyqvia 100mg immuneglobulin
- J1576 - Inj, panzyga, 500 mg
- J1580 - Garamycin gentamicin inj
- J1590 - Gatifloxacin injection
- J1595 - Injection glatiramer acetate
- J1596 - Inj, glycopyrrolate, 0.1 mg
- J1597 - Inj glycopyrrolate, glyrx-pf
- J1598 - Inj glycopyrrolate fres kabi
- J1599 - Ivig non-lyophilized, nos
- J1600 - Gold sodium thiomaleate inj
- J1602 - Golimumab for iv use 1mg
- J1610 - Glucagon hydrochloride/1 mg
- J1611 - Inj glucagon hcl, fresenius
- J1620 - Gonadorelin hydroch/ 100 mcg
- J1626 - Granisetron hcl injection